Stacey B, Barbara L Ch, Wei X. MMS2 encoding a ubiquitin-conjugating enzyme-like protein, is a member of the yeast error-free postreplication repair pathway Proceeding[J].National Academy of Science, 1998, 95(10): 5678-5683.
[2]
Yuan B, Xu Y, Woo JH, et al. Increased expression of mitotic check point genes in breast cancer cells with chromosomal instability[J]. Clin Cancer Res, 2006,12(2): 405-410.
[3]
Saito T, Hama S, Izumi H. Centrosome amplification induced by surviving suppression enhances both chromosome instability and radiosensitivity in glioma cells[J]. British Journal of Cancer, 2008, 15(98): 345-355.
Cheung HW, Chun A, Wang Q, et al. Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA_damaging agents[J]. Cancer Res, 2006, 66(8): 4357-4367.
[6]
Okuda T, Lin X, Trang J, et al. Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatin [J]. Mol Pharmacol, 2005, 67(6): 1852-1860.
[7]
Jason D, Trudy GO, Eleanor RC, et al.Suppression of Rev3, the catalytic subunit of Polζ,sensitizes drug-resistant lung tumors to chemotherapy[J]. PNAS, 2010, 30, 20786？20791.
Wu F, Lin X, Okuda T, et al. DNA polymerase zeta regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance[J]. Cancer Res, 2004, 64(21):8029 -8035.
